What are the potential risks of NeuroStar TMS Therapy?
The most commonly reported side effect related to treatment was scalp discomfort during treatment. This side effect was generally mild to moderate, and occurred less frequently after the first week of treatment. Less than 5% of patients treated with NeuroStar TMS Therapy discontinued treatment due to side effects. There is a theoretical risk of a seizure occurring. In the NeuroStar clinical trials, over 10,000 TMS treatments were safely administered with no occurrence of seizures. As an additional measure of safety, the NeuroStar TMS Therapy® System has a built-in mechanism to identify TMS treatments that are beyond established safety guidelines, preventing them from accidentally occurring. Not all patients will benefit from NeuroStar TMS Therapy. Patients should be carefully monitored for worsening symptoms, signs or symptoms of suicidal behavior, and/or unusual behavior. Families and caregivers should also be aware of the need to observe patients and notify their treatment provider i
